Peer Support for Post Intensive Care Syndrome Self-Management (PS-PICS)

October 30, 2020 updated by: Valerie Danesh, University of Texas at Austin

Peer Support for Post Intensive Care Syndrome Self-Management (PS-PICS)

A prospective, 2-arm, single-blind, randomized controlled clinical feasibility trial design is planned. Forty CCI survivors will be randomized (1:1) to either the PS-PICS (peer support) intervention or usual care (control) group.

Study Overview

Detailed Description

Randomized participants will complete 4 study assessments: 1) baseline data at hospital discharge; 2) baseline data post-hospital discharge and before the start of the weekly peer support intervention; 3) post-intervention at the conclusion of the 90-day weekly peer support intervention; and 4) follow-up at 6-months post-hospital discharge. The weekly peer support intervention will be delivered by a small pool of critical illness survivor peers (mentors) recruited from the study site from previous research. Peer support mentors will be trained in peer support and MI, and will deliver 3 months of weekly MI interventions (phone-based) to CCI survivors randomized to the intervention group. Participants randomized to the usual care group will not receive the weekly peer support/MI intervention but will receive the usual discharge planning services currently provided at hospital discharge. Participants in both groups will be contacted by the research team for 4 telephone-based assessments. The design will allow us to test the feasibility and potential impact of the PS-PICS intervention on social relationship measures, depression and self-management. Data collection and analyses are guided by the Individual and Family Self-Management Theory. The Individual and Family Self-Management Theory illustrates the interaction of the process of self-management with risk and protective factors, and short-term and long-term outcomes.

Study Type

Interventional

Enrollment (Anticipated)

40

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 65 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • age18 years or older
  • ICU length of stay 8 days or longer
  • expected to survive hospitalization with a discharge destination to home within 28 days of hospital discharge
  • diagnosed with 2 or more chronic conditions.

Exclusion Criteria:

  • death prior to hospital discharge
  • enrollment in Hospice services at the time of hospital discharge
  • non-communicative
  • no access to telephone
  • incarcerated

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: PS-PICS Peer Support Intervention
ICU mentors will be responsible for providing support to survivor participants randomized to the PS-PICS peer support intervention. Mentors will be trained in motivational interviewing techniques to engage mentees in goal setting and emotional management that is not readily accessible as part of discharge planning.
Mentors will trained in motivational interviewing and will conduct weekly telephone calls with participants randomized to the PS-PICS peer support intervention arm.
Placebo Comparator: Usual Care Group
A control intervention will be used to provide comparison data consistent with usual care (absence of structured peer support telephone intervention) to evaluate the impact of the PS-PICS peer support intervention.
Usual care.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Social Network Index
Time Frame: 3 months post-intervention
Social Network Index (SNI) to measure social relationships. The scale range is 0-12. The total score will be reported. The maximum total score is 12. Higher values represent a broader diversity of social networks and are classified as a better outcome.
3 months post-intervention

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Center for Epidemiologic Studies Depression Scale (CES-D)
Time Frame: 1-week Post-intervention
Center for Epidemiologic Studies Depression Scale (CES-D) to measure self-reported symptoms of depression The scale range is 0-60. The total score will be reported. The maximum total score is 60. Higher values represent self-reported symptoms of depression. Higher values represent a worse outcome.
1-week Post-intervention
Center for Epidemiologic Studies Depression Scale (CES-D)
Time Frame: 3 months post-intervention
Center for Epidemiologic Studies Depression Scale (CES-D) to measure self-reported symptoms of depression The scale range is 0-60. The total score will be reported. The maximum total score is 60. Higher values represent self-reported symptoms of depression. Higher values represent a worse outcome.
3 months post-intervention
Social Network Index
Time Frame: 1-week Post-intervention
Social Network Index (SNI) to measure social relationships. The scale range is 0-12. The total score will be reported. The maximum total score is 12. Higher values represent a broader diversity of social networks and are classified as a better outcome.
1-week Post-intervention
Patient Activation Measure
Time Frame: 1-week Post-intervention

Patient Activation Measure (PAM) Survey to measure self-reported active behavior in the self-management of chronic illness.

The scale range is 0-100. The total score will be reported. The maximum total score is 100. Higher values represent high levels of activation in self-management. Higher values represent a better outcome.

1-week Post-intervention
Patient Activation Measure
Time Frame: 3 months post-intervention

Patient Activation Measure (PAM) Survey to measure self-reported active behavior in the self-management of chronic illness.

The scale range is 0-100. The total score will be reported. The maximum total score is 100. Higher values represent high levels of activation in self-management. Higher values represent a better outcome.

3 months post-intervention
Patient-Reported Outcomes Measurement Information System (PROMIS) Fatigue Scale
Time Frame: 1-week Post-intervention

Patient-Reported Outcomes Measurement Information System (PROMIS) Fatigue Scale The scale range is 0-65. The total score will be reported. For each scale range provided, specify which values are considered to be a better or worse outcome (e.g., Do higher values represent a better or worse outcome?).

The maximum total score is 65. Higher values represent higher levels of fatigue.

1-week Post-intervention
Patient-Reported Outcomes Measurement Information System (PROMIS) Fatigue Scale
Time Frame: 3 months post-intervention

The Measure includes a scale. Please provide the following scale information:

Specify the full (unabbreviated) scale name and construct (i.e., indicate what the scale measures if not clear from name).

Patient-Reported Outcomes Measurement Information System (PROMIS) Fatigue Scale Include all scale ranges (i.e., minimum and maximum scores) required to interpret any values. For example, if the *total* score is reported, the *total* range should be provided. If *subscale* scores are reported, the range for each *subscale* should be provided.

The scale range is 0-65. The total score will be reported. For each scale range provided, specify which values are considered to be a better or worse outcome (e.g., Do higher values represent a better or worse outcome?).

The maximum total score is 65. Higher values represent higher levels of fatigue.

If subscales are combined to compute a total score, consider indicating how subscales are combined (summed, averaged, etc.).

N/A

3 months post-intervention
Short Form-36 (SF-36)
Time Frame: 1-week Post-intervention

Short Form-36 (SF-36) or 36-Item Short Form Health Survey Instrument The SF-36 has eight scaled scores; the scores are weighted sums of the questions in each section. Scores range from 0 - 100.

Lower scores = more disability, higher scores = less disability Sections: ∙ Vitality ∙ Physical functioning ∙ Bodily pain ∙ General health perceptions ∙ Physical role functi

1-week Post-intervention
Short Form-36 (SF-36)
Time Frame: 3 months post-intervention

Short Form-36 (SF-36) or 36-Item Short Form Health Survey Instrument The SF-36 has eight scaled scores; the scores are weighted sums of the questions in each section. Scores range from 0 - 100.

Lower scores = more disability, higher scores = less disability Sections: ∙ Vitality ∙ Physical functioning ∙ Bodily pain ∙ General health perceptions ∙ Physical role functi

3 months post-intervention

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Health services utilization
Time Frame: 1-week Post-intervention
Utilization of health services
1-week Post-intervention
Health services utilization
Time Frame: 3 months post intervention
Utilization of health services
3 months post intervention

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 20, 2020

Primary Completion (Anticipated)

October 27, 2020

Study Completion (Anticipated)

January 27, 2021

Study Registration Dates

First Submitted

November 20, 2018

First Submitted That Met QC Criteria

December 21, 2018

First Posted (Actual)

December 27, 2018

Study Record Updates

Last Update Posted (Actual)

November 2, 2020

Last Update Submitted That Met QC Criteria

October 30, 2020

Last Verified

October 1, 2020

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Sepsis

Clinical Trials on Peer Support with Motivational Interviewing

3
Subscribe